Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ANKRD49 pseudogene 2 is a genomic sequence on chromosome 12 classified as a pseudogene[7]. Unlike its parent gene ANKRD49, which encodes a protein with ankyrin repeat motifs involved in protein-protein interactions and has relevance in the context of cancers and cell fate modulation[2][3][4], ANKRD49P2 does not produce a functional protein and is not known to play a direct role in cellular signaling, therapeutic targeting, or human disease. Pseudogenes like ANKRD49P2 may retain sequence similarity to their parent genes but are typically inactive in protein synthesis and do not contribute to classical molecular pathways[5][7]. If you are seeking structured information for a therapeutic target, ANKRD49P2 should not be considered, since it does not encode a functional protein or participate directly in cellular functions relevant to drug discovery. Information about the functional ANKRD49 gene/protein is available and relevant in disease contexts, especially certain cancers[2][4], but not for ANKRD49P2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ANKRD49 pseudogene 2 (ANKRD49P2).